NCT06151379View on ClinicalTrials.gov

Muscle Parameters and Pathological Response in Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

October 20, 2023

Conditions
Neoadjuvant Chemotherapy
Interventions
OTHER

Neoadjuvant therapy

To measure muscle mass and predict pCR to NAC and its effect on clinical outcomes.

Trial Locations (1)

34782

AcıbademAH, Istanbul

All Listed Sponsors
lead

Acıbadem Atunizade Hospital

OTHER